p02.18. clinically meaningful differences in pain and disability after cupping treatment for chronic...

1
POSTER PRESENTATION Open Access P02.18. Clinically meaningful differences in pain and disability after cupping treatment for chronic neck pain: reanalysis of 4 randomized controlled trials R Lauche * , G Dobos, H Cramer From International Research Congress on Integrative Medicine and Health 2012 Portland, Oregon, USA. 15-18 May 2012 Purpose The assessment of clinically meaningful differences in patients self-reported outcomes has become more important when interpreting the results of clinical stu- dies. In conventional medicine these assessments are common; however, there is still doubt whether these results apply to complementary trials. The aim of this analysis is the determination of minimal clinically impor- tant differences (MCID) and substantial clinical benefits (SCB) in patients with chronic non-specific neck pain after cupping treatment. The MCID and SCB for pain intensity (VAS) and neck disability index (NDI) were esti- mated using common anchor-based methods. Methods The data set comprises a total of 200 patients participating in clinical trials on cupping therapy. The MCID and SCB for VAS and NDI were determined using receiver operat- ing characteristic (ROC) curve analysis with an adapted assessment of change in health status (SF36) as an anchor. This item asks the patients how they would rate their health in general now, compared to before treatment. Answer categories ranged from much better, somewhat better, about the same, somewhat worseto much worse.An ROC curve was constructed for each outcome. MCID derived from the ROC was the score with equal sensitivity and specificity to distinguish somewhat betterfrom about the same. The SCB was the score to distin- guish much betterfrom somewhat better. Results The calculated MCID was 8mm/21% for VAS and 3points/10.2% for NDI. The SCB was 26.5mm/66.1% for VAS and 8.4points/29.7% for NDI. Conclusion MCID and SCB for VAS in cupping trials are comparable to conventional trials although absolute and relative changes were slightly different. For NDI absolute and relative changes are smaller than in other trials, which might be due to the fact that scores were low in general. Altogether results support the assumption that patientsperceptions of treatment benefits in complementary trials are largely comparable to those in conventional trials. Published: 12 June 2012 doi:10.1186/1472-6882-12-S1-P74 Cite this article as: Lauche et al.: P02.18. Clinically meaningful differences in pain and disability after cupping treatment for chronic neck pain: reanalysis of 4 randomized controlled trials. BMC Complementary and Alternative Medicine 2012 12(Suppl 1):P74. University of Duisburg, Essen, Germany Lauche et al. BMC Complementary and Alternative Medicine 2012, 12(Suppl 1):P74 http://www.biomedcentral.com/1472-6882/12/S1/P74 © 2012 Lauche et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: h

Post on 30-Sep-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

POSTER PRESENTATION Open Access

P02.18. Clinically meaningful differences in painand disability after cupping treatment for chronicneck pain: reanalysis of 4 randomized controlledtrialsR Lauche*, G Dobos, H Cramer

From International Research Congress on Integrative Medicine and Health 2012Portland, Oregon, USA. 15-18 May 2012

PurposeThe assessment of clinically meaningful differences inpatients’ self-reported outcomes has become moreimportant when interpreting the results of clinical stu-dies. In conventional medicine these assessments arecommon; however, there is still doubt whether theseresults apply to complementary trials. The aim of thisanalysis is the determination of minimal clinically impor-tant differences (MCID) and substantial clinical benefits(SCB) in patients with chronic non-specific neck painafter cupping treatment. The MCID and SCB for painintensity (VAS) and neck disability index (NDI) were esti-mated using common anchor-based methods.

MethodsThe data set comprises a total of 200 patients participatingin clinical trials on cupping therapy. The MCID and SCBfor VAS and NDI were determined using receiver operat-ing characteristic (ROC) curve analysis with an adaptedassessment of change in health status (SF36) as an anchor.This item asks the patients how they would rate theirhealth in general now, compared to before treatment.Answer categories ranged from “much better”, “somewhatbetter”, “about the same”, “somewhat worse” to “muchworse.” An ROC curve was constructed for each outcome.MCID derived from the ROC was the score with equalsensitivity and specificity to distinguish “somewhat better”from “about the same”. The SCB was the score to distin-guish “much better” from “somewhat better”.

ResultsThe calculated MCID was 8mm/21% for VAS and3points/10.2% for NDI. The SCB was 26.5mm/66.1% forVAS and 8.4points/29.7% for NDI.

ConclusionMCID and SCB for VAS in cupping trials are comparableto conventional trials although absolute and relativechanges were slightly different. For NDI absolute andrelative changes are smaller than in other trials, whichmight be due to the fact that scores were low in general.Altogether results support the assumption that patients’perceptions of treatment benefits in complementary trialsare largely comparable to those in conventional trials.

Published: 12 June 2012

doi:10.1186/1472-6882-12-S1-P74Cite this article as: Lauche et al.: P02.18. Clinically meaningfuldifferences in pain and disability after cupping treatment for chronicneck pain: reanalysis of 4 randomized controlled trials. BMCComplementary and Alternative Medicine 2012 12(Suppl 1):P74.

University of Duisburg, Essen, Germany

Lauche et al. BMC Complementary and Alternative Medicine 2012, 12(Suppl 1):P74http://www.biomedcentral.com/1472-6882/12/S1/P74

© 2012 Lauche et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.